mucos
immun
establish
first
line
defenc
pathogen
enter
bodi
via
mucos
surfac
besid
elicit
local
system
immun
mucos
vaccin
strategi
noninvas
natur
may
increas
patient
complianc
reduc
need
vaccin
applic
train
personnel
rel
new
concept
mucos
immun
use
dna
vaccin
advantag
dna
vaccin
opportun
combin
genet
inform
variou
antigen
epitop
stimulatori
cytokin
enhanc
stabil
eas
product
make
class
vaccin
attract
suitabl
mucos
applic
contrast
area
intranas
vaccin
recent
studi
focus
pulmonari
immun
involv
pulmonari
immun
system
elicit
protect
immun
respons
inhal
pathogen
review
focus
dna
vaccin
deliveri
lung
promis
approach
prevent
pulmonaryassoci
diseas
caus
inhal
pathogen
attract
immunolog
featur
lung
site
immun
mechan
action
dna
vaccin
pulmonari
applic
vaccin
use
novel
deliveri
system
discuss
also
examin
pulmonari
diseas
prone
prevent
therapeut
intervent
applic
dna
vaccin
mucos
vaccin
deliveri
embrac
appeal
characterist
new
immun
strategi
invad
pathogen
major
human
pathogen
enter
bodi
via
mucos
surfac
contact
environ
nose
lung
gastrointestin
tract
mucos
vaccin
site
result
prevent
pathogen
entri
system
circul
local
immun
respons
induct
system
immun
prevent
infect
spread
addit
mani
practic
reason
make
mucos
vaccin
strategi
favour
comparison
inject
vaccin
easier
less
pain
administr
reduc
risk
associ
inject
vaccin
possibl
elimin
cold
chain
benefit
associ
mucos
vaccin
pulmonari
epithelium
crucial
role
host
defenc
inhal
pathogen
sinc
present
physic
barrier
includ
mucociliari
escal
concert
secret
antimicrobi
agent
present
mucu
layer
cover
airway
epithelium
prevent
colon
microorgan
addit
lung
mani
attract
immunolog
properti
organ
lymphoid
follicl
known
bronchoalveolar
lymphoid
tissu
balt
local
antigenpres
cell
apc
locat
ideal
sampl
antigen
enter
airway
found
lung
dna
vaccin
constitut
excit
new
approach
vaccin
develop
vaccin
construct
creat
insert
dna
encod
desir
antigen
bacteri
plasmid
vector
extent
plasmid
dna
abl
transfect
cell
depend
applic
rout
deliveri
system
use
encod
protein
express
transfect
cell
vivo
consequ
immun
respons
elicit
express
antigen
manuscript
present
rational
potenti
pulmonari
dna
immun
describ
major
featur
pulmonari
immunolog
give
overview
dna
vaccin
gener
associ
pulmonari
patholog
addit
discuss
main
work
perform
far
field
pulmonari
dna
vaccin
deliveri
argu
direct
vaccin
applic
lower
respiratori
tract
benefici
protect
inhal
pathogen
caus
lifethreaten
diseas
respiratori
tract
continu
beyond
larynx
trachea
divid
two
primari
bronchi
branch
bronchi
bronchiol
termin
bronchiol
branch
respiratori
bronchiol
alveolar
duct
alveoli
exchang
oxygen
co
blood
occur
proxim
airway
repres
pseudostratifi
columnar
epithelium
compos
ciliat
cell
basal
cell
smaller
number
goblet
cell
fig
goblet
cell
superfici
epithelium
mucou
cell
submucos
gland
secret
mucu
respiratori
line
distal
airway
epithelium
becom
less
multilay
gland
less
frequent
cell
becom
less
columnar
alveolar
surfac
compos
mainli
type
type
ii
pneumocyt
function
gasexchang
pneumocyt
surfact
secret
cell
respect
initi
barrier
prevent
pathogen
entri
airway
form
epitheli
cell
effect
separ
lumin
surfac
basolater
surfac
proxim
airway
larg
particl
n
diamet
trap
mucu
clear
mucociliari
escal
cough
addit
defenc
mechan
necessari
maintain
lung
steril
sinc
pathogen
smaller
cell
line
upper
lower
respiratori
tract
shown
produc
varieti
molecul
involv
inflammatori
immun
respons
secret
mediat
pulmonari
epithelium
capabl
recruit
activ
cell
innat
immun
system
kill
pathogen
initi
adapt
immun
respons
airway
constant
antimicrobi
environ
provid
constitut
express
chemic
defenc
induc
chemic
defenc
enhanc
respons
infect
secret
molecul
lung
categor
antimicrobi
substanc
chemotact
mediat
inflammatori
mediat
antimicrobi
product
secret
secretori
cell
mucosa
possess
direct
antimicrobi
activ
facilit
elimin
infecti
pathogen
phagocyt
defensin
cathelicidin
collectin
princip
antimicrobi
peptid
famili
express
respiratori
tract
anoth
import
molecul
antimicrobi
function
secret
pulmonari
epitheli
cell
immunoglobulin
iga
synthes
lamina
propria
dimer
specif
bind
secretori
compon
basolater
surfac
epitheli
cell
intern
complex
complex
transport
apic
surfac
epitheli
cell
releas
airway
neutral
virus
block
entranc
bacteri
agent
bodi
secret
product
associ
antimicrobi
function
lung
lysozym
lactoferrin
secretori
leukocyt
proteinas
inhibitor
slpi
phospholipas
transferrin
immunoglobulin
g
igg
chemotact
agent
induc
respons
varieti
stimuli
recruit
inflammatori
cell
lung
immun
cell
recruit
infect
area
releas
cytokin
like
granulocytemacrophag
colonystimul
factor
gmcsf
well
chemokin
express
adhes
molecul
airway
epitheli
cell
import
inflammatori
mediat
shown
play
import
role
pulmonari
host
defenc
includ
cytokin
tnfa
interferon
gamma
ifng
gmcsf
inflammatori
reaction
stay
local
within
infect
tissu
long
patholog
chang
occur
lung
injuri
may
result
cytokin
leakag
circul
system
cytokin
respons
pulmonari
epitheli
cell
act
antigenpres
immunoregulatori
cell
lung
bronchial
epitheli
cell
shown
express
hladr
class
ii
molecul
surfac
well
hladr
mrna
cell
abl
stimul
cell
express
mhc
class
ii
molecul
modul
immun
mediat
like
ifng
nevertheless
human
bronchial
epitheli
cell
express
costimulatori
molecul
requir
effici
apc
function
contrast
addit
mhc
class
ii
molecul
type
ii
alveolar
epitheli
cell
also
express
costimulatori
molecul
abl
deliv
costimulatori
signal
cell
show
anoth
role
pulmonari
epitheli
cell
antigenpres
immunoregulatori
cell
respiratori
tract
phagocyt
cell
like
macrophag
dendrit
cell
dc
essenti
protect
inhal
pathogen
play
role
innat
adapt
immun
respiratori
tract
failur
function
result
immunodefici
diseas
macrophag
versatil
popul
cell
mani
function
human
bodi
although
show
larg
divers
clear
cell
role
protect
preserv
tissu
integr
cell
remov
debri
gener
host
protect
infecti
pathogen
use
microbicid
capac
promot
specif
acquir
immun
antigen
present
capabl
regul
inflamm
effector
mechan
secret
solubl
mediat
pulmonari
macrophag
bone
marrow
deriv
cell
differenti
blood
monocyt
migrat
lung
recruit
capillari
mediat
chemotact
factor
popul
differ
lung
compart
differenti
matur
lung
macrophag
macrophag
found
pleura
interstitium
alveoli
pulmonari
blood
vessel
abl
migrat
one
lung
compart
subtl
differ
cell
physiolog
membran
antigen
express
function
observ
macrophag
differ
lung
compart
differ
probabl
attribut
respons
cell
locat
micromilieu
rather
fundament
differ
develop
macrophag
essenti
element
human
innat
immun
inhal
pathogen
togeth
compon
innat
immun
respons
pulmonari
surfact
mucu
secret
mucociliari
clearanc
antimicrobi
peptid
macrophag
abl
control
infect
lung
constantli
expos
environ
elimin
potenti
infecti
agent
achiev
phagocytosi
subsequ
digest
macrophag
enhanc
phagocyt
capabl
three
group
membran
receptor
facilit
opson
fc
receptor
fcgri
fcgrii
fcgriii
differ
igg
subclass
fcr
ige
iga
complement
receptor
lectin
receptor
mannos
receptor
scaveng
receptor
sr
macrophag
cell
surfac
associ
phagocytosi
apoptot
cell
patternrecognit
receptor
tolllik
receptor
tlr
associ
macrophag
stimul
ligat
microbi
ligand
follow
phagocytosi
activ
macrophag
start
releas
microbicid
enzym
reactiv
oxygen
intermedi
cell
stimulatori
proinflammatori
cytokin
success
nonspecif
pathogen
elimin
process
depend
pathogen
type
load
small
number
microorgan
elimin
alveolar
macrophag
alon
higher
inocula
requir
activ
b
cell
success
clearanc
macrophag
abil
elimin
specif
pathogen
also
depend
microorgan
speci
staphylococcu
aureu
phagocytos
kill
intracellularli
alveolar
macrophag
mycobacteria
spp
listeria
spp
legionella
pneumophila
readili
phagocytos
intracellular
kill
occur
allow
pathogen
resid
multipli
nonactiv
macrophag
decreas
suscept
infect
pathogen
could
due
interfer
tlr
ifngmedi
activ
pathway
macrophag
recent
suggest
humanmacrophag
plastic
critic
effect
pathogen
surviv
altern
activ
mode
macrophag
lead
antiinflammatori
phenotyp
persist
chronic
infect
macrophag
popul
lung
also
particip
induc
pulmonari
acquir
immun
respons
macrophag
abl
phagocytos
process
present
antigen
stimul
cell
primari
stimul
cell
clone
within
pulmonari
lymphoid
tissu
induc
alveolar
macrophag
migrat
bronchial
lymph
node
home
cell
paracort
area
pulmonari
macrophag
also
effector
function
acquir
immun
sinc
respons
cell
deriv
cytokin
respond
increas
microbicid
activ
macrophag
also
regulatori
function
acquir
immun
sinc
lung
constantli
expos
harm
pathogen
unregul
acquir
immun
respons
result
constant
state
inflamm
damag
normal
tissu
function
macrophag
popul
lung
heterogen
cell
exhibit
characterist
suppress
cell
rel
proport
induct
suppress
macrophag
develop
monocyt
regul
cell
cytokin
ifng
promot
induct
macrophag
promot
develop
suppress
cell
even
matur
macrophag
abl
switch
phenotyp
function
respons
cytokin
signal
ideal
characterist
cell
popul
migrat
constantli
differ
environ
within
lung
dendrit
cell
dc
part
innat
defenc
system
initi
modul
specif
nonspecif
immun
cell
profession
antigenpres
cell
present
tissu
dc
potent
stimul
cell
special
uptak
transport
process
present
antigen
dc
origin
bone
marrow
haematopoiet
stem
cell
circul
precursor
dc
enter
tissu
resid
immatur
dc
high
phagocyt
capac
phagocyt
capac
immatur
dc
establish
sever
mechan
phagocytosi
particl
microb
macropinocytosi
receptormedi
endocytosi
last
two
mechan
extrem
effici
antigen
sampl
requir
small
concentr
antigen
order
activ
dc
upon
stimul
immatur
dc
captur
antigen
migrat
drain
lymphoid
organ
differenti
matur
dc
matur
dc
result
decreas
capac
take
antigen
increas
present
capabl
matur
dc
distinguish
immatur
dc
loss
receptor
involv
antigen
uptak
increas
express
mhc
class
ii
molecul
costimulatori
molecul
like
matur
marker
follow
migrat
dc
present
previou
environ
cell
display
process
antigen
peptid
use
mhc
classi
mhc
classii
molecul
lead
cellular
humor
immun
respons
lung
pronounc
popul
dc
found
epitheli
line
conduct
airway
addit
popul
exist
submucosa
airway
epithelium
within
alveolar
septal
wall
alveolar
surfac
previous
shown
airway
epitheli
dc
turnov
time
day
local
stress
eg
inflammatori
state
turnov
pulmonari
dc
acceler
indic
import
local
antigen
surveil
local
antigen
challeng
result
higher
densiti
dc
airway
increas
express
activ
marker
level
matur
dc
migrat
peribronchi
lymph
node
increas
first
h
inflamm
howev
respons
quickli
wane
respiratori
dc
refractori
migrat
spite
continu
inflammatori
state
induct
refractori
state
also
result
transient
inhibit
dc
migrat
respons
second
pulmonari
stimulu
danger
signal
microbi
agent
recogn
dc
receptor
tolllik
receptor
tlr
ctype
lectin
receptor
clr
main
dc
receptor
engag
direct
recognit
characterist
molecular
pattern
antigen
recognit
pathogenassoci
molecular
pattern
like
bacteri
nucleic
acid
lipoprotein
lipopolysaccharid
lp
tlr
trigger
intracellular
signal
result
dc
matur
includ
upregul
costimulatori
molecul
mhc
molecul
express
proinflammatori
cytokin
ultim
lead
cell
activ
contrast
clr
recogn
specif
carbohydr
structur
pathogen
cellwal
compon
intern
pathogen
degrad
lysosom
compart
enhanc
process
present
dc
nevertheless
one
rememb
dc
act
bsentinelsq
bodi
henc
sampl
selfand
nonselfantigen
becom
evid
clr
dcsign
mannos
receptor
may
inhibit
stimulatori
signal
propos
tlr
clr
intersect
dictat
balanc
immuneactiv
toler
also
suggest
pathogen
hiv
mycobacterium
tuberculosi
target
dcsign
seek
immun
escap
bmisuseq
dcsign
result
pathogen
surviv
mechan
circumv
antigen
process
alter
tlrmediat
signal
skew
cell
respons
dc
activ
cell
result
immun
toler
activ
effector
cell
regulatori
cell
differ
cytokin
secret
profil
cell
polar
respons
addit
interact
cell
lymphoid
organ
dc
interact
cell
like
b
cell
natur
killer
nk
cell
differ
sometim
oppos
role
perform
dc
like
carri
cell
therefor
differ
subtyp
dc
identifi
subset
differ
phenotyp
local
function
two
subset
effect
balanc
plasmacytoid
dc
also
known
subset
local
cell
zone
lymphoid
tissu
associ
respons
subset
myeloid
dc
subset
local
intersti
tium
germin
center
variou
tissu
associ
respons
develop
two
function
differ
sublineag
could
explain
two
model
fig
singl
lineag
depend
local
environment
signal
function
plastic
model
two
differ
lineag
becam
commit
earli
development
stage
special
lineag
model
seem
realiti
mixtur
model
function
plastic
influenc
environment
cytokin
dc
precursor
clear
sever
factor
control
helper
balanc
immun
respons
initi
dc
dc
lineag
matur
signal
inflammatori
mediat
present
microenviron
bdefaultq
helper
respons
mucos
surfac
might
due
inher
properti
resid
dc
macrophag
popul
induct
respons
lung
requir
exposur
dc
appropri
stimulu
high
level
product
innat
immun
system
sens
pathogen
microorgan
tlr
major
class
patternrecognit
receptor
prr
recogn
pathogenassoci
molecular
pattern
pamp
tlr
discov
fruitfli
drosophila
conserv
throughout
evolut
shown
drosophila
mous
human
sever
speci
possess
similar
number
tlr
eleven
human
tlr
identifi
abl
recogn
structur
unrel
ligand
tlractiv
ligand
summar
tabl
includ
lipopolysaccharid
lp
bacteri
lipoprotein
unmethyl
cpg
oligodeoxynucleotid
doubl
strand
rna
dsrna
other
tlr
express
cell
surfac
featur
accord
natur
differ
tlr
ligand
found
local
cell
membran
local
intracellularli
lp
present
cell
wall
pathogen
therefor
recogn
upon
first
contact
host
cell
locat
cell
surfac
howev
bacteri
dna
resid
insid
bacteria
endolysosom
degrad
pathogen
cell
wall
requir
avail
recognit
present
endosom
compart
apc
except
lp
respons
intestin
epitheli
cell
local
golgi
apparatu
tlr
express
cell
locat
involv
first
line
defenc
like
mucos
epitheli
cell
macrophag
dc
dermal
endotheli
cell
neutrophil
higher
level
tlr
mrna
shown
express
tissu
expos
extern
environ
like
lung
gastrointestin
tract
well
immunolog
activ
site
peripher
blood
leukocyt
spleen
differ
cell
show
distinct
set
tlr
express
lead
differ
reactiv
microbi
molecul
suggest
cell
undergon
distinct
evolutionari
develop
pathway
enabl
recogn
differ
pathogen
dc
express
pattern
wide
explor
found
monocyt
preferenti
express
tlr
plasmacytoid
dc
express
role
tlr
pulmonari
infect
lung
diseas
intens
investig
review
ref
recent
express
known
tlr
report
airway
epitheli
cell
line
primari
bronchial
epitheli
cell
howev
tlr
highli
express
interact
inhal
pathogen
innat
immun
mediat
tlr
express
pulmonari
epitheli
cell
line
airway
network
apc
present
lung
explor
interact
pulmonari
pathogen
tlr
human
airway
epitheli
cell
express
activ
enhanc
host
defenc
increas
express
antimicrobi
peptid
human
hdefensin
shown
constitut
express
human
alveolar
bronchial
epitheli
cell
despit
intracellular
local
lung
epitheli
cell
respond
lp
respiratori
syncyti
viru
shown
upregul
mrna
protein
express
increas
local
membran
airway
epitheli
cell
increas
interact
lp
express
lung
epitheli
cell
promot
airway
inflamm
respons
rsv
infect
bacteri
infect
associ
recognit
gramneg
bacteri
lp
capac
recogn
major
cellwal
constitu
gramposit
bacteria
despit
gener
accept
model
involv
receptor
immun
respons
gramposit
bacteria
streptococcu
pneumonia
investig
confirm
point
debat
extent
involv
antibacteri
host
defenc
contradictori
vivo
result
obtain
like
due
differ
bacteri
challeng
model
determin
role
tlr
host
defenc
tuberculosi
also
focus
mainli
suggest
import
function
immun
tuberculosi
howev
signific
role
immun
tuberculosi
mous
model
although
evid
collect
show
involv
tlr
immun
pulmonari
pathogen
futur
work
defin
clearli
extent
host
defenc
pathogen
depend
tlr
signal
includ
bacteri
pathogen
load
involv
balt
mucosalassoci
lymphoid
tissu
malt
respiratori
tract
secondari
lymphoid
tissu
compris
nonencapsul
accumul
lymphoid
tissu
special
epitheli
cell
microfold
lumin
side
also
known
cell
princip
site
sampl
mucos
antigen
transfer
antigen
unchang
underli
dome
area
contain
mani
apc
cell
fig
stimul
antigen
result
gener
secretori
iga
antibodi
abl
cross
epitheli
membran
help
prevent
futur
entri
pathogen
mucos
site
furthermor
lymphocyt
stimul
antigen
mucos
induct
site
migrat
via
region
lymph
node
thorac
duct
blood
stream
mucos
effector
site
migrat
lead
iga
product
mucos
site
malt
gut
nasal
genitourinaryassoci
lymphoid
tissu
term
common
mucos
immun
system
cmi
cmi
appear
organ
select
enhanc
memori
seen
site
mucos
prime
compar
distant
mucos
site
nevertheless
role
iga
overemphas
discuss
respiratori
immun
sinc
cell
respons
promin
import
initi
local
immun
respons
lung
induct
cytotox
cell
respons
necessari
elimin
viral
bacteri
infect
balt
first
describ
follicular
aggreg
bronchial
wall
rabbit
locat
mainli
branch
site
bifurc
bronchial
tree
found
respiratori
epithelium
overlay
bronchial
lymphoid
structur
contain
cell
flatten
devoid
cilia
balt
show
high
variabl
speci
although
constitut
structur
seen
rabbit
rat
case
human
studi
human
balt
show
balt
constitut
structur
lung
healthi
adult
balt
observ
younger
adult
age
consist
smaller
follicl
describ
eg
rabbit
previous
discuss
detect
balt
human
adult
lung
associ
infect
inflamm
moyronquiroz
et
al
shown
influenza
infect
result
format
induc
bronchusassoci
lymphoid
tissu
ibalt
mice
lack
lymphoid
organ
spleen
lymph
node
peyer
patch
ibalt
capabl
prime
influenzaspecif
b
cell
abl
clear
viru
facilit
host
surviv
although
ibalt
resembl
constitut
balt
induc
antigenindepend
development
pathway
size
vari
wide
found
differ
pulmonari
compart
constitut
balt
find
point
although
constitut
balt
found
human
adult
tissu
induc
local
infect
howev
observ
anim
model
may
directli
extrapol
human
situat
concept
dna
vaccin
aros
observ
intramuscular
inject
plasmid
dna
contain
report
gene
result
protein
express
muscl
could
detect
even
month
inject
henc
suggest
administr
plasmid
dna
encod
antigen
protein
could
result
situ
express
antigen
follow
antigenspecif
immun
follow
year
mani
plasmid
dna
vector
encod
differ
bacteri
viral
parasit
cancer
antigen
construct
test
immunogen
protect
efficaci
anim
model
primat
recent
also
suggest
vaccin
serv
prevent
purpos
also
therapeut
vaccin
chronic
infect
might
restor
immun
control
prevent
sever
complic
diseas
dna
vaccin
hold
mani
distinct
advantag
comparison
recombin
protein
inactiv
pathogen
product
easi
similar
differ
plasmid
make
upscal
simpl
econom
ii
dna
stabl
higher
temperatur
properti
increas
shelflif
facilit
transport
distribut
vaccin
iii
differ
antigen
encod
vector
lead
express
multipl
antigen
protein
one
vaccin
final
iv
vaccin
advantag
induc
strong
cellular
immun
prefer
cytotox
lymphocyt
ctl
helper
type
cell
respons
although
immunolog
benefit
dna
vaccin
well
establish
three
safeti
issu
evalu
preclin
anim
model
evalu
dna
vaccin
studi
main
safeti
issu
risk
chromosom
integr
host
genom
might
result
activ
oncogen
disrupt
tumor
suppressor
gene
theoret
chanc
integr
event
low
mice
evid
integr
sensit
level
integr
nuclei
calcul
order
magnitud
lower
spontan
mutat
frequenc
nevertheless
safeti
concern
need
address
futur
clinic
trial
assur
result
human
subject
second
safeti
issu
possibl
plasmid
dna
elicit
antidna
antibodi
howev
antidna
antibodi
detect
sera
immun
mice
suggest
proper
purif
e
coli
would
like
prevent
pathogen
antidna
antibodi
product
third
safeti
concern
develop
toler
encod
antigen
issu
need
address
context
age
vaccin
individu
sinc
high
chanc
induc
toler
immun
newborn
immatur
immun
system
today
possibl
sequenc
complet
genom
pathogen
rel
short
period
time
identifi
antigen
pathogen
test
abil
induc
immun
new
genomebas
approach
vaccin
develop
term
brevers
vaccinologyq
approach
enabl
predict
new
potenti
antigen
test
much
faster
comparison
convent
vaccinolog
recent
exampl
sar
viru
viral
genom
sequenc
month
first
suggest
coronaviru
involv
diseas
approach
undeni
increas
amount
potenti
new
dna
vaccin
pathogen
caus
wide
rang
diseas
plasmid
vector
intend
use
dna
vaccin
need
certain
essenti
element
fig
bacteri
backbon
origin
replic
ori
usual
e
coli
facilit
amplif
larg
quantiti
dna
purif
obvious
activ
mammalian
cell
vivo
order
reduc
possibl
plasmid
integr
host
genom
ii
prokaryot
marker
gene
antibiot
resist
gene
facilit
select
organ
carri
plasmid
iii
strong
eukaryot
promot
drive
express
antigen
gene
usual
cytomegaloviru
cmv
simian
viru
iv
transcript
termin
ensur
mrna
appropri
termin
polya
signal
bovin
growth
hormon
bgh
v
dna
sequenc
encod
antigen
interest
vi
addit
mammalian
signal
sequenc
may
desir
facilit
protein
secret
may
requir
effici
antibodi
product
present
mhc
class
ii
molecul
dna
immun
result
antigen
express
vivo
gener
humor
cellular
immun
respons
major
advantag
dna
vaccin
abil
gener
mhc
class
irestrict
ctl
respons
demonstr
intramuscular
inject
plasmid
dna
encod
influenza
nucleoprotein
hiv
gag
env
antigen
hepat
b
viru
surfac
core
antigen
tuberculosi
antigen
heat
shock
protein
among
other
activ
ctl
dna
immun
occur
two
way
apc
directli
transfect
dna
ii
crossprim
nonapc
initi
produc
protein
encod
dna
vaccin
deliv
antigen
profession
apc
prime
mhc
class
restrict
ctl
respons
although
nonapc
eg
myocyt
take
produc
protein
cell
type
dna
administr
usual
lack
costimulatori
signal
need
ctl
activ
process
case
type
ii
alveolar
cell
shown
abl
express
costimulatori
molecul
deliv
costimulatori
signal
cell
therefor
present
addit
mechan
activ
ctl
respons
lung
fig
intramuscular
dna
vaccin
initi
helper
respons
bacteri
plasmid
dna
contain
unmethyl
cpg
motif
preval
vertebr
genom
dna
abl
stimul
apc
via
cpg
motif
trigger
product
proinflammatori
cytokin
therefor
gener
respons
may
gener
properti
dna
vaccin
nevertheless
rout
vaccin
vaccin
carrier
pronounc
effect
natur
immun
respons
elicit
review
exampl
applic
dna
vaccin
dgene
gunt
result
bias
respons
gene
gun
applic
system
use
vaccin
coat
gold
particl
introduc
intraderm
ballist
action
shown
respons
result
mode
applic
result
differ
site
vaccin
skin
vs
muscl
possibl
explan
gene
gun
deliv
dna
directli
cell
bypass
surfac
interact
apc
cpg
motif
abil
dna
vaccin
preferenti
induc
respons
may
particularli
import
prevent
intracellular
infect
requir
immun
optim
pathogen
erad
dna
immun
shown
induc
strong
humor
immun
respons
wide
varieti
antigen
anim
human
subject
antibodi
respons
increas
doserespons
manner
howev
optim
dose
given
plateau
antibodi
respons
reach
signific
effect
achiev
increas
dose
give
multipl
inject
sinc
dna
vaccin
gener
fig
schemat
represent
dna
vaccin
plasmid
construct
intend
immun
bacteri
deriv
contain
genet
sequenc
desir
antigen
vector
requir
strong
bacteri
origin
replic
antibiot
select
marker
strong
eukaryot
promot
usual
strong
viral
promot
like
pcmv
transcript
termin
fig
cytolyt
lymphocyt
ctl
activ
mechan
pulmonari
dna
immun
type
ii
alveolar
cell
found
express
costimulatori
molecul
abl
deliv
costimulatori
signal
cell
therefor
could
lead
ctl
activ
ctl
activ
mechan
involv
direct
transduct
profession
apc
dna
immun
b
crossprim
respiratori
epithelium
transfect
produc
antigen
transfer
profession
apc
directli
respons
activ
ctl
respons
c
enhanc
cytokin
product
subclass
antibodi
gener
bias
toward
product
also
seen
helper
respons
rout
dna
vaccin
bia
toward
product
gene
gun
case
antibodi
contribut
protect
challeng
relev
pathogen
indic
antigen
could
gener
neutral
antibodi
mani
antigen
pulmonari
pathogen
identifi
candid
vaccin
genomebas
classic
approach
correspond
dna
vaccin
synthes
evalu
immunogen
protect
efficaci
follow
section
discuss
possibl
benefit
pulmonari
vaccin
three
pathogen
caus
sever
diseas
airway
tuberculosi
respiratori
syncyti
viru
rsv
sarsassoci
coronaviru
sarscov
one
third
world
popul
infect
tuberculosi
bacillu
infect
peopl
develop
activ
diseas
lifetim
sinc
normal
healthi
person
immun
system
abl
control
diseas
howev
bacilli
stay
dormant
bodi
immunosuppress
state
chanc
develop
activ
diseas
increas
diseas
spread
individu
activ
pulmonari
tuberculosi
air
left
untreat
sick
person
infect
averag
peopl
everi
year
creat
aerosol
droplet
contain
bacilli
cough
sneez
etc
overal
million
peopl
die
everi
year
tuberculosi
reliev
situat
seem
faroff
especi
emerg
multidrug
resist
tuberculosi
mdrtb
deadli
combin
aid
tuberculosi
bstop
tb
initiativeq
worldembrac
program
commit
diagnosi
treatment
futur
prevent
tuberculosi
use
directli
observ
therapi
shortcours
program
dot
intern
recommend
tb
control
strategi
tuberculosi
better
control
differ
area
world
howev
clear
without
immun
difficult
stop
transmiss
diseas
prevent
vaccin
best
control
diseas
like
howev
vaccin
avail
tuberculosi
bacil
calmetteguerin
bcg
attenu
strain
mycobacterium
bovi
shown
protect
effect
mening
tuberculosi
children
howev
bcg
fail
prevent
pulmonari
tuberculosi
adult
mani
effort
direct
find
new
candid
vaccin
provid
broad
protect
diseas
infect
induc
lifelong
immunolog
memori
would
safe
stabl
inexpens
mycobacteri
infect
requir
cellmedi
immun
cell
essenti
optim
respons
sinc
dna
vaccin
induc
strong
cellular
immun
mani
preclin
studi
perform
use
differ
encod
antigen
first
report
dna
vaccin
tuberculosi
show
immunogen
protect
efficaci
mice
perform
use
antigen
kda
heat
shock
protein
tuberculosi
mani
antigen
mtb
kda
lipoptotein
put
phosphat
transport
receptor
pst
also
studi
provid
differ
degre
immunogen
protect
vaccin
encod
mycobacteri
protein
secret
mycobacteri
cultur
filtrat
expos
mycobacteri
cellwal
surfac
avail
complet
tuberculosi
genom
make
tuberculosi
dna
vaccin
popular
research
sinc
open
read
frame
orf
present
potenti
antigen
immedi
use
without
need
express
purifi
protein
gener
belief
success
tuberculosi
dna
protein
vaccin
requir
bcocktailq
immunogen
rsv
common
caus
sever
respiratori
diseas
infant
lead
hospit
children
first
year
life
account
approxim
case
viral
bronchiol
infant
caus
highest
morbid
infant
month
old
diseas
transmit
respiratori
secret
direct
contact
contamin
surfac
reinfect
rsv
common
life
howev
result
mild
cours
upper
respiratori
tract
infect
life
threaten
case
immunocompromis
individu
complet
immun
respons
rsv
includ
antibodi
product
helper
cell
respons
ctl
although
antibodi
rsv
protein
gener
rsv
infect
protect
incomplet
reinfect
possibl
even
presenc
high
level
viru
neutral
antibodi
nevertheless
local
antibodi
respiratori
tract
found
relat
protect
neutral
antibodi
found
correl
rel
protect
local
product
iga
concur
viru
clearanc
matern
antibodi
appear
protect
newborn
infect
howev
concentr
decreas
first
month
life
diseas
peak
infant
rsv
infect
associ
balanc
type
type
helper
respons
import
coordin
protect
immunopathogen
respons
promis
dna
vaccin
hold
prevent
rsv
encod
antigen
might
express
prolong
period
time
immun
infant
appropri
time
point
matern
antibodi
concentr
decreas
protect
level
vaccin
studi
far
perform
rodent
focus
two
glycoprotein
local
surfac
viru
f
protein
respons
fusion
viral
envelop
host
cell
membran
highli
conserv
rsv
subtyp
g
protein
mediat
attach
host
cell
surfac
respons
antigen
divers
rsv
subtyp
dna
vaccin
encod
rsvg
protein
induc
balanc
system
pulmonari
respons
neutral
antibodi
protect
rsv
infect
lower
respiratori
tract
mice
rat
rsvf
protein
encod
vector
show
induc
high
neutral
antibodi
titer
ctl
respons
protect
intranas
challeng
live
rsv
high
ifng
express
lung
challeng
furthermor
shown
addit
ligand
dna
vaccin
encod
rsvf
g
antigen
enhanc
viral
clearanc
paramet
immun
respons
rsv
challeng
sar
outbreak
atyp
pneumonia
first
report
guangdong
provinc
south
china
novemb
juli
record
case
sar
worldwid
death
viral
isol
serolog
assay
confirm
sarscov
primari
infecti
agent
genom
sequenc
defin
new
coronaviru
member
three
coronaviru
group
known
far
rout
transmiss
complet
establish
yet
immedi
observ
healthcar
worker
close
contact
sar
patient
high
risk
probabl
result
aerosolgener
procedur
airborn
transmiss
seem
possibl
support
case
commun
sar
outbreak
hong
kong
hous
complex
observ
face
mask
effici
precaut
medic
staff
protect
need
better
understand
exact
transmiss
mechan
droplet
definit
whether
sar
obligatori
preferenti
opportunist
airborn
transmit
although
sar
emerg
year
ago
data
concern
vaccin
candid
alreadi
start
accumul
promis
vaccin
candid
two
structur
protein
nucleocapsid
protein
n
spike
protein
shown
group
patient
sar
produc
antibodi
n
protein
less
produc
antibodi
protein
anoth
studi
use
neutral
assay
pseudotyp
viru
shown
sarscov
elicit
strong
humor
neutral
respons
protein
mani
effort
direct
find
specif
domain
epitop
protein
induc
strong
product
anti
sarscov
neutral
antibodi
advanc
develop
vaccin
therapeut
sar
dna
vaccin
encod
protein
sarscov
induc
neutral
antibodi
cell
respons
protect
immun
mice
protect
mechan
depend
cell
immun
sinc
cell
deplet
affect
vaccineinduc
protect
furthermor
adopt
cell
transfer
reduc
pulmonari
viral
replic
recipi
anim
contrast
passiv
transfer
purifi
igg
immun
mice
provid
protect
similar
observ
dna
vaccin
dna
immun
use
n
protein
encod
plasmid
result
specif
antin
antibodi
specif
ctl
respons
sinc
model
shown
protein
protect
futur
experi
detect
best
vaccin
candid
prove
combin
structur
antigen
induc
best
viral
protect
mucos
immun
promis
ration
strategi
combat
infecti
agent
enter
bodi
via
mucos
surfac
site
antigen
encount
determin
immun
respons
circul
antigenspecif
cell
prime
mucos
tissu
increas
home
commit
origin
mucos
site
furthermor
vaccin
one
mucos
induct
site
induc
immun
respons
distant
effector
mucos
site
common
mucos
immun
system
secondari
exposur
antigen
therefor
lung
prefer
vaccin
site
pathogen
enter
bodi
via
airway
induc
pulmonari
diseas
pulmonari
immun
strategi
describ
date
involv
nasal
applic
due
eas
administr
belief
vaccin
site
stimul
respiratori
mucos
immun
interact
nasalassoci
lymphoid
tissu
nalt
although
induc
local
system
immun
respons
main
mucos
effect
remain
upper
airway
may
lead
insuffici
respiratori
immun
pulmonari
pathogen
use
murin
model
respiratori
reoviru
infect
shown
stimul
nalt
alon
induc
optim
antibodi
respons
effect
immun
achiev
combin
upper
lower
respiratori
tract
infect
combin
approach
use
intranas
intratrach
administr
simultan
recent
use
african
green
monkey
attenu
parainfluenza
viru
express
sar
coronaviru
spike
protein
administ
induc
detect
neutralis
antibodi
sar
coronaviru
serum
furthermor
comparison
upper
respiratori
tract
immun
intranas
lower
respiratori
tract
immun
intratrach
use
inactiv
influenza
viru
prototyp
splitsubunit
vaccin
show
intratrach
immun
effect
induc
local
system
immun
respons
anoth
comparison
intratrach
intranas
intramuscular
deliveri
microencapsul
mix
yersinia
pesti
subunit
vaccin
v
subunit
show
intratrach
immun
result
higher
immun
respons
respiratori
tract
domin
local
igg
antigen
inhal
vaccin
poorli
investig
far
despit
report
success
sever
diseas
model
effici
immun
respons
demonstr
tuberculosi
measl
influenza
emphas
great
potenti
deep
lung
immun
prevent
pulmonari
infect
measl
vaccin
explor
pulmonari
administr
focus
develop
aerosol
measl
vaccin
sever
year
support
effort
chang
administr
rout
vaccin
main
reason
abil
mass
vaccin
campaign
possibl
administr
nonmed
personnel
importantli
abil
elimin
transmiss
diseas
like
hiv
hepat
b
bloodborn
pathogen
poor
practic
inject
safeti
procedur
dri
powder
formul
measl
vaccin
pulmonari
aerosol
deliveri
appear
viabl
approach
retain
vaccin
potenc
elimin
cold
chain
requir
immun
futur
studi
vaccin
aim
erad
respiratori
diseas
need
compar
current
applic
method
vaccin
pulmonari
rout
although
promis
approach
pulmonari
immun
present
sever
disadvantag
first
disadvantag
possibl
hypersensit
respons
vaccin
prepar
therefor
immun
studi
check
specif
immun
respons
vaccin
determin
local
hypersensit
respons
lung
patholog
result
vaccin
andor
formul
anoth
immunolog
concern
pulmonari
immun
develop
mucos
toler
respons
antigen
deposit
lung
establish
solubl
antigen
deliv
respiratori
mucosa
without
inflammatori
signal
sensitis
cell
induc
toler
system
challeng
final
practic
disadvantag
small
volum
liquidformul
appli
small
anim
model
especi
mice
best
immunolog
character
anim
serv
model
mani
investig
diseas
argument
howev
may
mute
case
vaccin
given
dri
powder
formul
pulmonari
mucos
immun
employ
dna
vaccin
rather
new
yet
opinion
promis
vaccin
approach
present
mani
appeal
properti
addit
practic
issu
mention
mucos
vaccin
deliveri
gener
approach
enabl
vaccin
immunocompromis
individu
sinc
threat
virul
encount
live
attenu
vaccin
inhal
dna
vaccin
recent
describ
use
plasmid
encod
ovalbumin
hepat
b
surfac
antigen
hlaa
tcell
epitop
tuberculosi
shown
increas
immun
measur
antibodi
cytokin
product
suggest
immun
respons
highli
depend
encod
antigen
investig
whether
applic
method
hold
advantag
comparison
common
vaccin
procedur
intramuscular
inject
furthermor
mechan
immun
induct
explor
emphasi
interact
antigen
pulmonari
dc
dc
migrat
lymphoid
organ
migrat
immun
cell
lung
pulmonari
immun
role
balt
part
cmi
also
defin
context
pulmonari
dna
vaccin
order
clarifi
whether
lung
influenc
immun
mucos
effector
site
sinc
iga
alway
present
bronchoalveolar
lavag
role
pulmonari
immun
diseas
protect
elucid
goal
dna
deliveri
system
achiev
longterm
express
antigen
encod
dna
vaccin
protect
dna
enzymat
degrad
enhanc
immun
respons
although
dna
vaccin
show
good
potenc
preclin
anim
model
result
primat
ensu
phase
clinic
trial
human
disappoint
emphas
need
develop
deliveri
applic
strategi
increas
immun
respons
review
dna
carrier
categor
two
group
viral
nonvir
vector
group
present
differ
characterist
advantag
drawback
virus
appeal
vector
natur
abil
incorpor
dna
host
genom
order
deliv
dna
therapeut
purpos
viral
carrier
modifi
elimin
induct
pathogen
effect
ensur
safe
transgen
express
main
disadvantag
viral
vector
detect
immun
system
induc
immun
respons
direct
allow
applic
repeat
dose
usual
need
gene
therapi
genet
immun
viral
dna
vaccin
deliveri
research
perform
mainli
adenovirus
poxvirus
vaccinia
virus
replicationincompet
adenovir
vector
express
hiv
antigen
shown
effici
induc
humor
cellular
immun
respons
best
result
usual
achiev
dna
vaccin
prime
adenovir
boost
intranas
immun
adenovir
vector
induc
greater
mucos
iga
respons
hiv
antigen
recombin
adenoviru
express
tuberculosi
provid
potent
protect
tuberculosi
challeng
model
intranas
administr
howev
detect
infect
central
nervou
system
could
limit
util
rout
deliveri
adenovir
vector
highli
attenu
vaccinia
viral
vector
modifi
vaccinia
ankara
mva
use
hiv
antigen
multiepitop
construct
deriv
plasmodium
falciparum
antigen
cancerassoci
antigen
tuberculosi
vector
present
highest
immunogen
given
booster
dose
induc
effici
protect
challeng
anim
model
mva
vector
carri
cancer
p
falciparum
antigen
present
seriou
advers
effect
clinic
trial
human
subject
although
nonvir
vector
present
disadvantag
demonstr
viral
vector
less
effici
induc
high
transgen
express
level
carrier
encapsul
complex
adsorb
dna
complex
adsorpt
usual
base
electrostat
forc
neg
charg
dna
posit
charg
carrier
carrier
usual
abl
protect
dna
nucleas
degrad
depend
system
present
control
releas
profil
carrier
vari
consider
integr
target
moieti
endosom
disrupt
agent
nuclear
local
signal
order
improv
tissu
target
intracellular
deliveri
fig
essenti
qualiti
deliveri
system
biocompat
enabl
multipl
administr
low
toxic
effici
gene
deliveri
suffici
level
antigen
produc
result
protect
immun
respons
describ
synthet
vector
dna
vaccin
deliveri
lipid
polym
base
lipidbas
dna
deliveri
system
lipidbas
deliveri
system
cation
lipid
posit
charg
ph
independ
posit
charg
lipid
interact
neg
charg
dna
form
complex
lipidbas
formul
dna
complex
cation
moieti
entrap
within
aqueou
phase
liposom
dehydrationrehydr
procedur
liposom
complex
lipoplex
evalu
tuberculosi
anthrax
encod
antigen
shown
improv
immunogen
protect
efficaci
mannosyl
liposom
synthes
target
apc
vivo
enhanc
immun
respons
complex
plasmid
encod
model
antigen
ovalbumin
entrap
dna
aqueou
compart
liposom
shown
effect
complex
result
better
immun
respons
hepat
b
surfac
antigen
assum
lipo
fig
schemat
illustr
intern
intracellular
traffick
plasmid
dna
deliv
nonvir
carrier
system
some
improv
immunogen
dna
vaccin
facilit
uptak
apc
emuls
anoth
deliveri
system
deriv
lipid
could
deliv
dna
vaccin
effici
surfac
charg
oilinwat
ow
submicron
emuls
base
potent
squalen
adjuv
cation
use
dotap
immun
dna
vaccin
encod
hiv
gag
protein
adsorb
posit
charg
emuls
result
significantli
enhanc
immun
respons
mice
rabbit
polymerbas
dna
deliveri
system
system
includ
variou
polym
posit
charg
physiolog
ph
abl
complex
dna
natur
synthet
deriv
polym
manipul
chemic
modif
achiev
cell
target
higher
transfect
effici
qualiti
major
import
futur
use
human
biocompat
biodegrad
low
toxic
chitosan
deacetyl
form
natur
origin
polysaccharid
chitin
extens
explor
pharmaceut
excipi
deliveri
vehicl
chitosan
polym
vari
molecular
weight
viscos
degre
deacetyl
solubl
chitosan
highli
depend
degre
deacetyl
ph
ph
valu
lower
chitosan
posit
charg
abl
form
complex
anion
fig
biodegrad
biocompat
present
excel
toxic
profil
furthermor
chitosan
shown
mucoadhes
enhanc
mucos
absorpt
open
tight
junction
therefor
favour
vaccin
deliveri
mucos
tissu
oral
deliveri
chitosan
nanoparticl
load
dna
encod
peanut
allergi
antigen
gener
protect
immun
addit
nanoparticl
enhanc
immun
respons
given
intranas
cocktail
plasmid
dna
encod
rsv
antigen
lyophil
formul
dna
encod
ctl
epitop
protein
rsv
complex
chitosan
induc
signific
reduct
viral
load
lung
intranas
immun
mice
oral
deliveri
chitosan
nanoparticl
load
dna
encod
protein
toxoplasma
gondii
present
enhanc
immunogen
studi
point
chitosan
effici
carrier
dna
vaccin
polyethyleneimin
pei
polym
variou
molecular
weight
highest
cation
charg
densiti
potenti
everi
third
atom
amin
group
proton
fig
polym
first
shown
effici
gene
deliveri
system
dna
encod
human
growth
hormon
hgh
complex
pei
induc
high
level
antibodi
singl
administr
gene
express
analysi
demonstr
pei
abl
activ
immun
system
without
dna
activ
gene
involv
cellular
process
like
cellcycl
regul
oncogenesi
differenti
evid
suggest
care
monitor
toxic
effect
immun
pei
poli
llactidecoglycolid
plga
polym
one
commonli
investig
materi
deliveri
therapeut
fig
biocompat
biodegrad
present
low
toxic
plga
microparticl
nanoparticl
describ
effici
encapsul
plasmid
dna
encapsul
dna
plasmid
plga
microparticl
shown
elicit
protect
immun
respons
tumor
stimul
durabl
cell
respons
tumorassoci
antigen
cytochrom
releas
dna
improv
addit
polyh
amino
ester
plga
microparticl
enhanc
antigenspecif
reject
tumor
cell
vivo
compar
convent
plga
microparticl
cation
plga
microparticl
design
enabl
adsorpt
dna
surfac
instead
encapsul
plga
microparticl
bear
cation
agent
cetyltrimethylammonium
bromid
ctab
enhanc
immun
respons
gag
protein
intramuscular
intranas
administr
mice
potent
respons
also
achiev
dna
encod
envelop
protein
hepat
c
viru
deliveri
system
current
evalu
clinic
trial
genet
vaccin
immunotherapeut
agent
dna
encod
hpv
antigen
epitop
encapsul
plga
microparticl
zycosmgi
pharma
http
wwwzycoscom
dna
encod
hiv
clade
b
gag
env
antigen
adsorb
plga
microparticl
niaid
http
wwwaidsinfonihgovclin
trial
pulmonari
deliveri
dna
vaccin
use
carrier
system
rare
explor
exist
data
describ
optim
formul
aerosol
gene
deliveri
evalu
gene
express
lung
addit
induc
transfect
cell
vitro
lung
tissu
vivo
carrier
pulmonari
genet
vaccin
deliveri
explor
dna
encod
pulmonari
antigen
relev
anim
model
prove
immunogen
protect
efficaci
vivo
result
regard
immunogen
lung
pulmonari
administr
dna
carrier
system
exist
peidna
polyplex
chitosan
nanoparticl
develop
pulmonari
compat
formul
novel
deliveri
system
dna
vaccin
enabl
prevent
lifethreaten
diseas
caus
respiratori
pathogen
era
new
pathogen
genet
sequenc
month
antigen
moieti
detect
quickli
dna
vaccin
constitut
promis
next
gener
protect
agent
lifethreaten
virus
bacteria
pulmonari
dna
vaccin
hold
promis
induc
local
system
immun
respons
promot
protect
inhal
airborn
pathogen
review
present
potenti
lung
vaccin
site
special
antigen
sampl
initi
immun
use
epitheli
cell
immun
cell
local
lymphoid
tissu
evalu
dna
vaccin
airborn
pathogen
need
determin
protect
efficaci
addit
new
nontox
pulmonari
adjuv
deliveri
system
character
investig
vivo
order
perform
challeng
studi
airborn
pathogen
given
aerosol
collabor
work
appropri
biohazard
facil
author
execut
experi
benefici
enabl
research
studi
full
potenti
pulmonari
appli
vaccin
